ADHD Medication Recall 2025: What Charlotte Residents Need to Know About Vyvanse Generic and Medication Safety in Recovery
In late October 2025, Sun Pharmaceutical Industries initiated a nationwide recall of several lots of lisdexamfetamine dimesylate capsules—the generic version of Vyvanse, one of America’s most commonly prescribed ADHD medications—due to “failed dissolution specifications.” The pills didn’t dissolve properly during laboratory testing, potentially reducing the medication’s effectiveness for the millions of people who depend on it for ADHD symptom management. For Charlotte, NC residents, particularly those in addiction treatment or recovery, this recall raises important questions about medication safety, stimulant abuse risks, and the complex relationship between ADHD and substance use disorders.
At Nova Transformations in Charlotte, we understand that ADHD medications like Vyvanse (lisdexamfetamine), Adderall, and Ritalin play a critical role in managing attention deficit hyperactivity disorder—but they also carry abuse potential and require careful management, especially for individuals with addiction histories. The connection between ADHD and substance use disorders is well-established, with people with ADHD having significantly higher rates of addiction than the general population. Understanding medication recalls, safe stimulant use, and alternative ADHD management strategies is essential for protecting both your health and your recovery.
This comprehensive guide covers the 2025 ADHD medication recall details, how to check if your medication is affected, the relationship between ADHD and addiction, risks of stimulant abuse, medication safety in recovery, and comprehensive dual diagnosis treatment available in Charlotte.
Lisdexamfetamine (Vyvanse/generic) prescriptions dispensed in the U.S. in 2023
Understanding the 2025 ADHD Medication Recall
What Happened?
On October 28, 2025, Sun Pharmaceutical Industries Inc. initiated a voluntary recall of lisdexamfetamine dimesylate capsules due to “Failed Dissolution Specifications.” The FDA classified this as a Class II recall on October 30, 2025.
Key Facts:
- Medication: Lisdexamfetamine dimesylate (generic Vyvanse)
- Manufacturer: OHM Laboratories (New Jersey)
- Distributor: Sun Pharmaceutical Industries Inc.
- Problem: Pills failed to dissolve properly during laboratory stability testing
- Risk level: Class II (may cause temporary health consequences, but serious harm unlikely)
- Scope: Multiple lots in 100-count bottles, 10mg-70mg dosages
What Is Lisdexamfetamine (Vyvanse)?
- Drug class: Stimulant medication (amphetamine derivative)
- Brand name: Vyvanse (manufactured by Takeda Pharmaceuticals)
- Uses: ADHD treatment in children and adults; binge eating disorder
- How it works: Increases dopamine and norepinephrine in the brain, improving focus and reducing impulsivity
- Controlled substance: Schedule II (high potential for abuse and dependence)
The Dissolution Problem
What “failed dissolution specifications” means:
- Dissolution testing measures how quickly a pill breaks down when swallowed
- For medication to work properly, it must dissolve at expected rate so active ingredient is absorbed
- Pills that don’t dissolve properly may not deliver full dose to bloodstream
- Result: Medication may be less effective—symptoms may not be adequately controlled
This is the same issue that caused the recent atorvastatin (Lipitor) recall affecting 141,000+ bottles.
Affected Lots and How to Check Your Medication
Recalled lots (100-count bottles):
| Strength | Lot Numbers | Expiration Dates |
|---|---|---|
| 10 mg | AD42468, AD48705 | 2/28/2026 – 4/30/2026 |
| 20 mg | AD42469, AD48707 | 2/28/2026 – 4/30/2026 |
| 30 mg | AD42470, AD48708 | 2/28/2026 – 4/30/2026 |
| 40 mg | AD48709, AD50894 | 4/30/2026 – 5/31/2026 |
| 50 mg | AD48710, AD50895 | 4/30/2026 – 5/31/2026 |
| 60 mg | AD48711, AD50896 | 4/30/2026 – 5/31/2026 |
| 70 mg | AD48712, AD50898 | 4/30/2026 – 5/31/2026 |
How to check if your medication is recalled:
- Look at your prescription bottle
- Find the lot number (usually printed on label or bottle)
- Check if it matches any recalled lot numbers above
- Look at expiration date to confirm
- If uncertain, call your pharmacy—they can verify
⚠️ Important: Do NOT Stop Taking ADHD Medication Abruptly
Even if your medication is part of the recall:
- DO NOT stop taking it suddenly without medical guidance
- Stopping stimulants abruptly can cause withdrawal symptoms
- Continue taking medication while arranging replacement
- Contact your pharmacy or doctor for guidance
- Pharmacies will arrange replacement from different manufacturer
Taking potentially less-effective medication is better than suddenly stopping, which can cause withdrawal, rebound ADHD symptoms, and other complications.
What to Do If Your Medication Is Recalled
- Continue taking your medication until you can get a replacement
- Contact your pharmacy immediately to arrange for replacement from different manufacturer
- Don’t panic— Class II recall means low risk of serious harm
- Monitor symptoms—if ADHD symptoms seem worse, discuss with doctor
- Refund or replacement: Pharmacy will handle return process
Of people with ADHD will develop a substance use disorder in their lifetime—2-3x higher than general population
The Complex Relationship Between ADHD and Addiction
The connection between ADHD and substance use disorders is well-documented and critically important for anyone taking stimulant medications or in addiction recovery.
ADHD Increases Addiction Risk
People with ADHD have dramatically higher rates of addiction:
- 25-40% lifetime substance use disorder risk (vs. 10-15% in general population)
- Earlier onset: Start using substances younger
- Faster progression: Develop addiction more quickly
- More severe: Harder time achieving recovery
- Multiple substances: More likely to abuse multiple drugs
Why the Connection?
1. Self-Medication
- Undiagnosed/untreated ADHD: Using substances to manage symptoms unknowingly
- Stimulants (cocaine, meth): Temporarily improve focus and energy
- Marijuana: Attempting to calm hyperactivity and racing thoughts
- Alcohol: Reducing restlessness and social anxiety
- Nicotine: Improving concentration (very high smoking rates in ADHD)
2. Impulsivity and Poor Judgment
- ADHD impairs impulse control and risk assessment
- Difficulty considering consequences before acting
- Experimentation with drugs happens without thinking through risks
- Can’t “just say no” as easily
3. Seeking Stimulation
- ADHD brain seeks novelty and intense experiences
- Drugs provide stimulation and excitement
- Boredom is intolerable—substances relieve it
4. Executive Function Deficits
- Difficulty planning and organizing
- Poor time management leads to stress
- Emotional dysregulation
- Substances become coping mechanisms
5. Co-occurring Disorders
- ADHD commonly co-occurs with depression, anxiety, bipolar disorder
- These conditions independently increase addiction risk
- Combined burden makes substance use more likely
Does ADHD Medication Prevent or Cause Addiction?
This is a critical question with nuanced answer:
Research shows treating ADHD with medication REDUCES addiction risk:
- Properly treated ADHD = less likely to self-medicate with substances
- Improved impulse control from medication helps resist drug use
- Better life functioning reduces stress driving substance abuse
- Studies consistently find stimulant treatment protective against addiction
However, ADHD medications themselves can be abused:
- Schedule II controlled substances with addiction potential
- People may misuse their own prescriptions (taking more than prescribed)
- Diversion (selling or giving medication to others) is common
- Non-medical use is prevalent, especially in college
The key: Proper medical supervision, appropriate diagnosis, and monitoring for misuse.
Stimulant Abuse and Addiction
Prescription stimulants like Vyvanse, Adderall, and Ritalin—intended to treat ADHD—are commonly abused for their effects.
Why People Abuse Prescription Stimulants
- Academic performance: “Study drugs” to enhance focus and stay awake
- Weight loss: Stimulants suppress appetite
- Euphoria: High doses produce cocaine-like high
- Energy: Combating fatigue
- Party drugs: Mixing with alcohol to stay alert while drinking
Signs of Stimulant Abuse
- Taking more medication than prescribed
- Running out of prescription early
- “Doctor shopping” for multiple prescriptions
- Crushing and snorting pills (faster, more intense high)
- Using without prescription (buying from others)
- Combining with other substances
- Preoccupation with obtaining medication
- Continued use despite negative consequences
Dangers of Stimulant Abuse
- Cardiovascular: Heart attack, stroke, sudden death
- Psychiatric: Paranoia, psychosis, severe anxiety
- Addiction: Physical and psychological dependence
- Sleep deprivation: Days without sleep causing serious impairment
- Malnutrition: Appetite suppression leading to dangerous weight loss
- High-risk behaviors: Impulsivity worsened
- Overdose: Can be fatal
Stimulant Withdrawal
Stopping stimulants after regular abuse causes withdrawal:
- Extreme fatigue and need for sleep
- Depression (sometimes severe with suicidal thoughts)
- Increased appetite
- Slowed thinking and movement
- Vivid, unpleasant dreams
- Intense cravings
🚨 Stimulant Addiction is Serious
Despite being prescription medications, stimulants:
- Are Schedule II controlled substances (same as cocaine)
- Cause severe psychological dependence
- Have dangerous cardiovascular effects
- Can trigger psychosis
- Require professional treatment for addiction
If you or someone you know is abusing prescription stimulants, seek help immediately. At Nova Transformations, we specialize in treating stimulant addiction.
Medication Safety for People in Recovery
For individuals in addiction recovery, taking prescribed ADHD medication requires careful consideration and monitoring.
Should People in Recovery Take ADHD Medication?
This is controversial, but research supports:
YES, when appropriate:
- Untreated ADHD is major relapse risk
- Proper ADHD treatment improves recovery outcomes
- With appropriate safeguards, stimulants can be used safely
- Benefits often outweigh risks
Requires strict protocols:
- Accurate ADHD diagnosis (not just self-report)
- Stable recovery (typically 6-12 months minimum)
- Honest disclosure about addiction history
- Close monitoring by both addiction specialist and prescriber
- Accountability measures (pill counts, prescription monitoring)
- Family/sponsor involvement
Non-Stimulant ADHD Medication Alternatives
For people with active addiction or high relapse risk, non-stimulant options include:
1. Atomoxetine (Strattera)
- Non-stimulant ADHD medication
- No abuse potential
- Not a controlled substance
- Takes 4-6 weeks to work fully
- Less effective than stimulants for some people
2. Guanfacine (Intuniv)
- Non-stimulant option
- Originally blood pressure medication
- Helps with impulsivity and hyperactivity
- No abuse potential
3. Clonidine (Kapvay)
- Similar to guanfacine
- Non-stimulant
- Can help with sleep and hyperactivity
4. Bupropion (Wellbutrin)
- Antidepressant with some ADHD benefit
- Also helps with smoking cessation
- No abuse potential
Behavioral Approaches to ADHD
- Cognitive Behavioral Therapy (CBT) for ADHD: Specific skills training
- Organization systems: Planners, apps, routines
- Environmental modifications: Reducing distractions
- Exercise: Proven to improve ADHD symptoms
- Sleep hygiene: Regular sleep critical
- Nutrition: Protein-rich diet, limiting sugar
- Mindfulness and meditation: Improving focus
Dual Diagnosis Treatment at Nova Transformations
At Nova Transformations in Charlotte, NC, we provide specialized dual diagnosis treatment for individuals with both ADHD and substance use disorders.
Our ADHD + Addiction Treatment Approach
1. Comprehensive Assessment
- Proper ADHD diagnosis (not just assumption)
- Differentiating ADHD from substance-induced symptoms
- Understanding relationship between ADHD and substance use
- Identifying co-occurring conditions (depression, anxiety, trauma)
2. Integrated Treatment
- Treating both conditions simultaneously
- Understanding ADHD as contributing to addiction
- Addressing self-medication patterns
- Not forcing choice between ADHD treatment and recovery
3. Medication Management
- Stabilize recovery first before introducing stimulants when possible
- Non-stimulant options prioritized (Strattera, Intuniv, Wellbutrin)
- If stimulants necessary: Strict protocols with accountability
- Close monitoring for misuse
- Coordination between addiction and ADHD prescribers
4. ADHD-Specific Therapy
- CBT for ADHD: Skills training (organization, time management, emotional regulation)
- Psychoeducation: Understanding ADHD and how it affects addiction
- Coping strategies: Managing ADHD without substances
- Relapse prevention: Recognizing how ADHD symptoms trigger cravings
5. Structure and Routine
- Highly structured program beneficial for ADHD
- Clear schedules and expectations
- Breaking tasks into manageable pieces
- Accountability and follow-through support
6. Family Education
- Helping families understand ADHD-addiction connection
- Supporting proper medication use
- Accountability without enabling
- Recognizing warning signs
7. Long-Term Support
- Ongoing medication monitoring
- Continued therapy
- Support groups
- Regular check-ins
✨ Why Nova for ADHD + Addiction Treatment
- Specialized dual diagnosis expertise
- Understanding ADHD-addiction connection
- Integrated treatment approach
- Medication management with safety protocols
- Non-stimulant ADHD treatment options
- ADHD-specific therapy (CBT for ADHD)
- Structure and support for ADHD brains
- Charlotte location convenient throughout Mecklenburg County
- Insurance accepted
Get Expert Dual Diagnosis Treatment for ADHD and Addiction in Charlotte
Struggling with both ADHD and substance abuse? You’re not alone. At Nova Transformations in Charlotte, our specialized dual diagnosis team understands the complex relationship between ADHD and addiction, providing integrated treatment that addresses both conditions safely and effectively for lasting recovery.
We accept most major insurance plans. Unfortunately, we do not accept Medicare or Medicaid at this time.
Confidential assessment available. ADHD and addiction are both treatable. Recovery is possible.
Frequently Asked Questions
The 2025 recall affects specific lots of lisdexamfetamine dimesylate (generic Vyvanse) manufactured by OHM Laboratories and distributed by Sun Pharmaceutical Industries. To check if your medication is recalled, look at your prescription bottle for the lot number and compare it to the recalled lots which include 10mg (lots AD42468, AD48705 expiring 2/28-4/30/2026), 20mg (lots AD42469, AD48707), 30mg (lots AD42470, AD48708), 40mg (lots AD48709, AD50894 expiring 4/30-5/31/2026), 50mg (lots AD48710, AD50895), 60mg (lots AD48711, AD50896), and 70mg (lots AD48712, AD50898). These medications failed dissolution specifications meaning pills didn’t dissolve properly during laboratory testing which could reduce effectiveness. This is a Class II recall meaning the medication may cause temporary health consequences but serious harm is unlikely. Important: Do NOT stop taking your ADHD medication abruptly even if it’s part of the recall as stopping stimulants suddenly can cause withdrawal symptoms including extreme fatigue, depression, and severe ADHD symptom rebound. Continue taking your medication while contacting your pharmacy to arrange for replacement from a different manufacturer. Your pharmacist will handle the return and provide non-recalled medication. If you’re uncertain whether your medication is affected, call your pharmacy—they can verify lot numbers and expiration dates immediately.
People with ADHD have 2-3 times higher lifetime risk of developing substance use disorders (25-40% vs. 10-15% in general population) due to multiple interconnected factors. First, self-medication is extremely common where people with undiagnosed or untreated ADHD unknowingly use substances to manage symptoms with stimulants like cocaine temporarily improving focus and energy, marijuana attempting to calm hyperactivity and racing thoughts, alcohol reducing restlessness and social anxiety, and nicotine improving concentration (smoking rates in ADHD are very high). Second, impulsivity and poor judgment—core ADHD symptoms—impair risk assessment making it harder to “just say no” to experimentation and difficulty considering consequences before acting. Third, ADHD brains seek novelty and intense stimulation making drugs’ excitement particularly appealing especially since boredom is intolerable for those with ADHD. Fourth, executive function deficits including poor planning, time management difficulties, and emotional dysregulation create stress for which substances become maladaptive coping mechanisms. Fifth, co-occurring conditions like depression, anxiety, and bipolar disorder which commonly accompany ADHD independently increase addiction risk creating combined vulnerability. Research shows properly treating ADHD with medication actually REDUCES addiction risk by eliminating need to self-medicate, improving impulse control helping resist drug use, and better life functioning reducing stress driving substance abuse. However, ADHD medications themselves are Schedule II controlled substances with abuse potential requiring careful medical supervision. At Nova Transformations in Charlotte, we specialize in treating the complex interplay between ADHD and addiction with integrated dual diagnosis care.
Yes, people in addiction recovery can take ADHD medication safely when appropriate, though this requires careful consideration, proper protocols, and close monitoring. Research supports that untreated ADHD is a major relapse risk since ADHD symptoms (impulsivity, poor judgment, emotional dysregulation) directly undermine recovery, and proper ADHD treatment actually improves recovery outcomes. However, this requires several critical safeguards including accurate ADHD diagnosis through comprehensive evaluation (not just self-report as many people seeking stimulants claim ADHD), stable recovery typically meaning 6-12 months of sobriety before introducing stimulants when possible, complete honesty about addiction history with prescribing physician, close monitoring by both addiction specialist and ADHD prescriber coordinating care, accountability measures like pill counts and prescription drug monitoring program checks, and family or sponsor involvement in medication management. Non-stimulant ADHD medications should be prioritized for people in early recovery or with high relapse risk including atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and bupropion (Wellbutrin)—all are effective for ADHD without abuse potential. If stimulants are medically necessary, protocols include starting after recovery stabilization, using long-acting formulations (harder to abuse), weekly or bi-weekly prescriptions (not monthly), observed dosing when indicated, and immediate discontinuation if any misuse detected. Additionally, behavioral approaches to ADHD including CBT for ADHD skills training, organization systems, environmental modifications, regular exercise, proper sleep, and mindfulness can significantly reduce ADHD symptoms without medication. At Nova Transformations in Charlotte, our dual diagnosis program specializes in safely managing ADHD in people with addiction histories. We don’t force you to choose between treating your ADHD and maintaining recovery—we treat both simultaneously with appropriate safeguards. Call (704) 961-9322 for expert dual diagnosis care.
Yes, Nova Transformations provides specialized dual diagnosis treatment for individuals with both ADHD and substance use disorders in Charlotte, North Carolina. Our comprehensive ADHD plus addiction treatment includes accurate ADHD diagnosis differentiating true ADHD from substance-induced symptoms and evaluating the relationship between ADHD and substance use patterns, integrated treatment addressing both conditions simultaneously rather than sequentially understanding ADHD as contributing factor to addiction and addressing self-medication patterns, expert medication management prioritizing non-stimulant ADHD medications like Strattera, Intuniv, and Wellbutrin when appropriate, implementing strict safety protocols with accountability if stimulants are medically necessary, and coordinating between addiction specialists and ADHD prescribers, ADHD-specific therapy including Cognitive Behavioral Therapy for ADHD teaching organization skills, time management, emotional regulation, psychoeducation about ADHD-addiction connection, coping strategies managing ADHD without substances, and relapse prevention recognizing how ADHD symptoms trigger cravings, highly structured programming beneficial for ADHD brains with clear schedules, accountability, task breakdown, and follow-through support, family education helping families understand the ADHD-addiction connection and support proper medication use, and comprehensive long-term support with ongoing medication monitoring, continued therapy, support groups, and regular check-ins. We understand that ADHD and addiction commonly co-occur with 25-40% of people with ADHD developing substance use disorders, that untreated ADHD dramatically increases relapse risk, and that integrated treatment of both conditions produces the best outcomes. Available through our Partial Hospitalization Program (PHP) and Intensive Outpatient Program (IOP). Call (704) 961-9322 for confidential assessment and expert dual diagnosis care in Charlotte.
References and Resources
- U.S. Food and Drug Administration (FDA). (2025). Enforcement Report: Lisdexamfetamine Dimesylate Capsules Recall. Retrieved from https://www.fda.gov/
- Newsweek. (2025). Nationwide ADHD Medication Recall Update as FDA Sets Risk Level. Retrieved from https://www.newsweek.com/
- Wilens, T. E., & Upadhyaya, H. P. (2007). Impact of substance use disorder on ADHD and its treatment. Journal of Clinical Psychiatry, 68(8), e20.
- National Institute on Drug Abuse (NIDA). (2024). Prescription Stimulants DrugFacts. Retrieved from https://nida.nih.gov/
- Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). Adults with ADHD and Co-Occurring Substance Use Disorders. Rockville, MD: SAMHSA.
- Biederman, J., et al. (2008). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44(4), 269-273.
- Wilens, T. E., et al. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179-185.
- American Academy of Child & Adolescent Psychiatry. (2024). ADHD and Substance Abuse.
- Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). (2024). ADHD and Substance Use Disorders. Retrieved from https://chadd.org/
Charlotte-Area Resources:
- Nova Transformations Charlotte: (704) 961-9322
- Pharmacy Recall Information: Contact your pharmacy directly
- SAMHSA National Helpline: 1-800-662-HELP (4357)
- CHADD (ADHD Support): https://chadd.org/
Medical Disclaimer: This article is for informational and educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Never stop taking prescribed medications without consulting your healthcare provider. ADHD and substance use disorders require professional treatment. Always consult qualified healthcare providers for medication questions and treatment decisions. If experiencing a medical emergency, call 911 immediately.
Last Updated: November 8, 2025 | Author: Nova Transformations Clinical Team | Location: Charlotte, North Carolina
